290 related articles for article (PubMed ID: 21040362)
1. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour.
Machlenkin S; Pinsk I; Tulchinsky H; Ziv Y; Sayfan J; Duek D; Rabau M; Walfisch S
Colorectal Dis; 2011 Oct; 13(10):1110-5. PubMed ID: 21040362
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
Wilkinson MJ; Fitzgerald JE; Strauss DC; Hayes AJ; Thomas JM; Messiou C; Fisher C; Benson C; Tekkis PP; Judson I
Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of rectal gastrointestinal stromal tumors.
Tielen R; Verhoef C; van Coevorden F; Reyners AK; van der Graaf WT; Bonenkamp JJ; van Etten B; de Wilt JH
J Surg Oncol; 2013 Mar; 107(4):320-3. PubMed ID: 22806955
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors.
Seshadri RA; Rajendranath R
J Cancer Res Ther; 2009; 5(4):267-71. PubMed ID: 20160360
[TBL] [Abstract][Full Text] [Related]
7. [Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate].
Nakashima S; Fujita Y; Matsuo H; Ariyoshi Y; Fukuda K; Fujiyama J; Masuyama M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1932-4. PubMed ID: 23267934
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
[TBL] [Abstract][Full Text] [Related]
9. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
[TBL] [Abstract][Full Text] [Related]
10. [Three cases of giant rectal gastrointestinal stromal tumor].
Nakamoto K; Nagahara H; Noda E; Inoue T; Maeda K; Ohira G; Amano R; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1984-6. PubMed ID: 22202260
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
12. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
13. The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor.
Wang JP; Wang T; Huang MJ; Wang L; Kang L; Wu XJ
Am J Clin Oncol; 2011 Jun; 34(3):314-6. PubMed ID: 20622646
[TBL] [Abstract][Full Text] [Related]
14. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).
Fiore M; Palassini E; Fumagalli E; Pilotti S; Tamborini E; Stacchiotti S; Pennacchioli E; Casali PG; Gronchi A
Eur J Surg Oncol; 2009 Jul; 35(7):739-45. PubMed ID: 19110398
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
Turner J; Batus M; Leslie W; Coogan C; Saclarides TJ
Am Surg; 2010 Aug; 76(8):E110-2. PubMed ID: 21513625
[No Abstract] [Full Text] [Related]
16. Six months neoadjuvant imatinib improves resectability potential of gastric stromal tumors in Egyptian patients.
Saied GM; Kensarah AM
Int J Surg; 2010; 8(2):105-8. PubMed ID: 19944196
[TBL] [Abstract][Full Text] [Related]
17. DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour.
Revheim ME; Hole KH; Bruland OS; Haugland HK; Hall KS; Seierstad T
Acta Oncol; 2011 Jan; 50(1):148-50. PubMed ID: 21110775
[No Abstract] [Full Text] [Related]
18. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
19. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].
Sassa M; Kobayashi Y; Sugeno H; Iwadate M; Suzuki S; Endo Y; Nakamura I; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2013 Jul; 40(7):937-41. PubMed ID: 23863741
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors treatment in the Imatinib era. The role of fair indication.
Vendettuoli M; Pironi D; Pontone S; Panarese A; La Gioia G; Arcieri S; Romani AM; Palazzini G; Filippini A
Minerva Chir; 2012 Apr; 67(2):165-73. PubMed ID: 22487918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
